CBS 2019
CBSMD教育中心
English

推荐文献

科研文章

荐读文献

2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed Robotics in percutaneous cardiovascular interventions The Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels Syncope After Percutaneous Coronary Intervention The year in cardiovascular medicine 2020: interventional cardiology The Impact of Proximal Vessel Tortuosity on the Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further Research Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO Trial Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial Association of preoperative glucose concentration with myocardial injury and death after non-cardiac surgery (GlucoVISION): a prospective cohort study
|<<... 3 4 5 6 7 8 9 ...>>|

Consensus2019 Dec 27[Online ahead of print]

JOURNAL：Catheter Cardiovasc Interv. Article Link

SCAI Expert Consensus Statement Update on Best Practices for Transradial Angiography and Intervention

AR Shroff, Rajiv Gulati, DE Drachman et al. Keywords: transradial angiography; ultrasound; ulnar artery access; non-invasive testing of collateral flow; radial artery occlusion prevention

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top